Skip to main content

Table 1 Clinical characteristics and thyroid functions tests of patients with hyperthyroidism (GD and TNG) and controls.

From: Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men

Parameters GD (n = 31) TNG (n = 21) Controls (n = 25) P1 P2
Age (years) 43 ± 10 44 ± 8 42 ± 11 >0.05 >0.05
Body weight (kg) 69.5 ± 8.0 68.0 ± 12.0 86.0 ± 10.0 <0.05 <0.05
Hight (cm) 170 ± 10 173 ± 10 173 ± 13 >0.05 >0.05
BMI (kg/m 2 ) 27.5 ± 3.1 27.8 ± 2.8 30.2 ± 2.9 >0.05 >0.05
Duration of disease (years) 2.9 ± 1.2 3.0 ± 1.5 - - -
Serum TSH (uU/ml) 0.89 ± 0.47 1.01 ± 0.36 3.31 ± 0.76 <0.01 <0.01
Serum Free T3 (pmol/l) 6.14 ± 2.32 5.62 ± 1.42 4.57 ± 1.43 <0.01 <0.05
Serum Free T4 (pmol/l) 20.8 ± 6.2 19.8 ± 5.7 17.9 ± 4.26 <0.05 <0.05
  1. P1: Graves' diseases (GD) vs control
  2. P2: Toxic multinodular goiter (TNG) vs control
  3. Significant P < 0.05